Novel Role of Base Excision Repair in Mediating Cisplatin Cytotoxicity

Cross-Link Structure Affects Replication-Independent DNA Interstrand Cross-Link Repair in Mammalian Cells

(2010) Erica M. Hlavin et al.   BIOCHEMISTRY

Downregulation of XPF–ERCC1 enhances cisplatin efficacy in cancer cells☆

(2010) Sanjeevani Arora et al.   DNA REPAIR

A novel link to base excision repair?

(2010) David M. Wilson et al.   TRENDS IN BIOCHEMICAL SCIENCES

APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells

(2009) Dong Wang et al.   LUNG CANCER

The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links

(2009) A. Z. Al-Minawi et al.   NUCLEIC ACIDS RESEARCH

Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy

(2008) P.H. Clingen et al.   BIOCHEMICAL PHARMACOLOGY

Recognition of Cisplatin−DNA Interstrand Cross-Links by Replication Protein A†

(2008) Steve M. Patrick et al.   BIOCHEMISTRY

Mechanism of Replication-Coupled DNA Interstrand Crosslink Repair

(2008) Markus Räschle et al.   CELL

Human Methyl Purine DNA Glycosylase and DNA Polymerase   Expression Collectively Predict Sensitivity to Temozolomide

(2008) R. N. Trivedi et al.   MOLECULAR PHARMACOLOGY

Clinical relevance of the homologous recombination machinery in cancer therapy

(2007) Kiyoshi Miyagawa   CANCER SCIENCE

Unique Properties of DNA Interstrand Cross-Links of Antitumor Oxaliplatin and the Effect of Chirality of the Carrier Ligand

(2007) Jana Kasparkova et al.   CHEMISTRY-A EUROPEAN JOURNAL